Gilead Sciences to Present at the Punk, Ziegel & Company's Investor Symposium on Monday, November 22nd; Webcast Available Through Gilead Corporate Website

Gilead Sciences to Present at the Punk, Ziegel & Company's Investor Symposium on Monday, November 22nd; Webcast Available Through Gilead Corporate Website

Business Wire - November 19, 2004

FOSTER CITY, Calif.-- Gilead Sciences, Inc. (Nasdaq:GILD) announced today that its corporate presentation will be webcast from the Punk, Ziegel & Company's Investor Symposium, "New Agents to Treat HIV," in New York, NY. This webcast may be accessed via the company's corporate website at www.gilead.com.

John F. Milligan, PhD, Gilead's Executive Vice President and Chief Financial Officer, will provide an overview of Gilead's HIV Franchise on Monday, November 22nd at 10:15 a.m. Eastern Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the live presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases worldwide. The company has seven marketed products, and focuses its research and clinical programs on anti-infectives. Headquartered in Foster City, CA, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

CONTACT: Gilead Sciences, Inc.

Susan Hubbard, 650-522-5715 (Investor Relations)

SOURCE: Gilead Sciences, Inc.

041119
BW041112

Copyright © 2004 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .